Canada Markets closed

Khiron Life Sciences Corp. (KHRNF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.3621-0.0079 (-2.14%)
At close: 3:48PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.3700
Open0.3498
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.3469 - 0.3700
52 Week Range0.2161 - 1.6000
Volume197,649
Avg. Volume134,287
Market Cap41.542M
Beta (5Y Monthly)1.95
PE Ratio (TTM)N/A
EPS (TTM)-0.3020
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Khiron Provides Corporate Update: Surpasses 1,000 Medical Cannabis Patient Prescription Milestone
    CNW Group

    Khiron Provides Corporate Update: Surpasses 1,000 Medical Cannabis Patient Prescription Milestone

    The update reflects the Company's revenue generation activities and continued position as the only company with medical cannabis sales in Colombia."Through our branded clinics in Colombia, third-party pharmacies, educations programs, and expanded global markets we are fully focused on revenue generation and meeting patient needs in Latin America and globally.

  • Khiron to Commercialize Medical Cannabis in Peru
    CNW Group

    Khiron to Commercialize Medical Cannabis in Peru

    TORONTO, July 23, 2020 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, announced today that it has received import licenses and all necessary authorizations from the  Directorate General of Drug Supplies and Drugs (DIGEMID) for the import and commercialization of full spectrum, high-CBD medical cannabis products from Khiron Colombia into Peru.  

  • GlobeNewswire

    Khiron Announces Change of Auditor

    TORONTO, July 21, 2020 -- Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMZC), announces that MNP LLP (the “Former.